CLBIO — Corline Biomedical AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Corline Biomedical AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	SAS	SAS	SAS	SAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	41.6	26.2	17	17.7	20.6
Net Total Accounts Receivable
Net Total Receivables	2.77	8.47	5.22	2.63	2.31
Prepaid Expenses
Total Current Assets	44.8	36	23.8	21	24
Net Property, Plant And Equipment	0.182	0.28	0.314	0.219	0.162
Net Intangible Assets
Long Term Investments
Total Assets	102	102	100	94.8	98.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	9.43	7.19	6.79	7.85	4.82
Total Long Term Debt
Total Debt
Total Liabilities	9.43	7.19	6.79	7.85	4.82
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	92.2	94.6	93.3	86.9	93.8
Total Liabilities & Shareholders' Equity	102	102	100	94.8	98.6
Total Common Shares Outstanding